AQR Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.08M | Buy |
630,529
+316,834
| +101% | +$4.04M | ﹤0.01% | 1450 |
|
|
2025
Q4 | $2.82M | Buy |
313,695
+103,290
| +49% | +$1.42M | ﹤0.01% | 1924 |
|
|
2025
Q3 | $3.63M | Buy |
210,405
+73,865
| +54% | +$910K | ﹤0.01% | 1636 |
|
|
2025
Q2 | $1.28M | Buy |
136,540
+45,665
| +50% | +$375K | ﹤0.01% | 2052 |
|
|
2025
Q1 | $646K | Buy |
90,875
+55,118
| +154% | +$557K | ﹤0.01% | 2277 |
|
|
2024
Q4 | $417K | Buy |
+35,757
| New | +$558K | ﹤0.01% | 2341 |
|
|
2022
Q4 | – | Sell |
-5,048
| Closed | -$282K | – | 2252 |
|
|
2022
Q3 | $282K | Sell |
5,048
-3,230
| -39% | -$200K | ﹤0.01% | 1963 |
|
|
2022
Q2 | $428K | Sell |
8,278
-17,707
| -68% | -$899K | ﹤0.01% | 1735 |
|
|
2022
Q1 | $1.89M | Sell |
25,985
-14,715
| -36% | -$1.25M | ﹤0.01% | 1215 |
|
|
2021
Q4 | $4.81M | Sell |
40,700
-6,777
| -14% | -$849K | 0.01% | 839 |
|
|
2021
Q3 | $6.37M | Buy |
47,477
+11,901
| +33% | +$1.8M | 0.01% | 763 |
|
|
2021
Q2 | $5.76M | Buy |
35,576
+3,872
| +12% | +$302K | 0.01% | 815 |
|
|
2021
Q1 | $2.54M | Buy |
31,704
+11,414
| +56% | +$766K | ﹤0.01% | 1088 |
|
|
2020
Q4 | $1.1M | Sell |
20,290
-5,454
| -21% | -$198K | ﹤0.01% | 1455 |
|
|
2020
Q3 | $512K | Buy |
25,744
+5,169
| +25% | +$108K | ﹤0.01% | 1714 |
|
|
2020
Q2 | $432K | Sell |
20,575
-23,448
| -53% | -$398K | ﹤0.01% | 1793 |
|
|
2020
Q1 | $538K | Sell |
44,023
-15,614
| -26% | -$210K | ﹤0.01% | 1558 |
|
|
2019
Q4 | $875K | Buy |
59,637
+23,099
| +63% | +$321K | ﹤0.01% | 1557 |
|
|
2019
Q3 | $488K | Buy |
+36,538
| New | +$583K | ﹤0.01% | 1764 |
|
|
2018
Q4 | – | Sell |
-10,519
| Closed | -$301K | – | 2243 |
|
|
2018
Q3 | $301K | Buy |
10,519
+1,055
| +11% | +$30.7K | ﹤0.01% | 2106 |
|
|
2018
Q2 | $259K | Sell |
9,464
-5,327
| -36% | -$129K | ﹤0.01% | 2163 |
|
|
2018
Q1 | $312K | Buy |
+14,791
| New | +$364K | ﹤0.01% | 2040 |
|
|
2017
Q4 | – | Sell |
-22,640
| Closed | -$563K | – | 2259 |
|
|
2017
Q3 | $563K | Buy |
22,640
+10,137
| +81% | +$191K | ﹤0.01% | 1897 |
|
|
2017
Q2 | $200K | Buy |
+12,503
| New | +$175K | ﹤0.01% | 2129 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
